SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-289040
Filing Date
2020-11-09
Accepted
2020-11-09 16:02:41
Documents
13
Period of Report
2020-11-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d819407d8k.htm   iXBRL 8-K 25259
2 EX-5.1 d819407dex51.htm EX-5.1 3833
  Complete submission text file 0001193125-20-289040.txt   149310

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvta-20201105.xsd EX-101.SCH 3067
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20201105_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20201105_pre.xml EX-101.PRE 10951
6 EXTRACTED XBRL INSTANCE DOCUMENT d819407d8k_htm.xml XML 3273
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 201297638
SIC: 8071 Services-Medical Laboratories